Moreover, in vitro findings suggested that AMPK/NR4A1 suppression-mediated mitochondrial homeostasis might be the underlying mechanism in the SG treatment of DCM (Figures 5, 6). This evidence concerns the gene NR4A1 and familial dilated cardiomyopathy.